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Abstract
Aristolochia (馬兜鈴 mǎ dōu ling) is an important genus widely cultivated and had long been known for their extensive 
use in traditional Chinese medicine. The genus has attracted so much great interest because of their numerous biological 
activity reports and unique constituents, aristolochic acids (AAs). In 2004, we reviewed the metabolites of Aristolochia 
species which have appeared in the literature, concerning the isolation, structural elucidation, biological activity and 
literature references. In addition, the nephrotoxicity of aristolochic acids, biosynthetic studies, ecological adaptation, 
and chemotaxonomy researches were also covered in the past review. In the present manuscript, we wish to review the 
various physiologically active compounds of different classes reported from Aristolochia  species in the period between 
2004 and 2011. In regard to the chemical and biological aspects of the constituents from the Aristolochia  genus, 
this review would address the continuous development in the phytochemistry and the therapeutic application of the 
Aristolochia  species. Moreover, the recent nephrotoxicity studies related to aristolochic acids would be covered in this 
review and the structure-toxicity relationship would be discussed.
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Introduction
There are about 500 species in the genus Aristolochia 
and the majority of these species are distributed in the 
tropical region, with some exceptions range as north 
as Canada, Scandinavia, and Northern Japan. They 
may grow as climbing vines, as short creeping herbs 
and a few are shrub-like (Hutchinson, 1973; Watson 
and Dallwitz, 1992; Gonzalez, 1999). Aristolochia 
species are herbaceous perennials, undershrubs or 
shrubs, often scandent, scrambling, twining, sometimes 
lianas, usually with prostrate or tuberous rhizomes or 
rootstocks, and alternate, pinnate, polymorphic or lobed 
leaves bearing essential oils. Species of Aristolochia 
were widely distributed in tropical, subtropical and 
temperate regions of the world. They are known to 
occur in Asia, Africa, North and South America and 
Australia but there is a wide distribution across tropical 
Asia (Liu and Lai, 1976; How, 1985; Hou, 1996). 
Various species of Aristolochia  have been used in the 
folk and traditional medicines as medicaments and 
tonics (Andrei, 1977; Correa, 1978; Balbach, 1979; 
Duke, 1985; Duke and Ayensu, 1985; Simoes et al, 
1986; Lopes et al, 2001), especially in the traditional 
Chinese medicines (Jiangsu New Medicine College, 
1977; Li, 1977; Pharmacopeia of China, 1985; Tang 
and Eisenbrand, 1992; Bensky, 1993). Some species 
This is an open access article under the CC BY-NC-ND license.
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have been used in the form of crude drugs as anodynes, 
antiphlogistics, and detoxicants in Mainland China 
(Perry, 1980). In our previous review article (Wu et al, 
2005), the purification, structural elucidation, and the 
biological activity of metabolites of Aristolochia species 
have been covered and moreover the nephrotoxicity 
of aristolochic acids, biosynthetic studies, ecological 
adaptation, and chemotaxonomy researches were also 
cited. In this present manuscript, we aimed to address 
the continuous development regarding the presences 
of the various metabolites identified from Aristolochia 
species and also their divergent bioactivities.
Chemical Constituents
In the period between 2004 and 2011 over eighteen 
species of Aristolochia  have been investigated for 
chemical constituents around the world, and various 
constituents have been characterized (Table 1). The 
secondary metabolites from Aristolochia species cover 
16 major groups classified by their chemical structures, 
including aristolochic acids and esters, aristolactams, 
apo rph ine s ,  p ro tobe rbe r ine s ,  i soqu ino l i ne s , 
benzylisoquinolines, amides, flavonoids, lignans, 
biphenyl ethers, coumarins, tetralones, terpenoids, 
benzenoids, steroids, and others. The aristolochic acids 
were host of phenanthrene derived metabolites in which 
the aristolactams also possessed the similar skeleton. 
The identified terpenoids can further be divided into 
three subgroups: mono-, sesqui-, and diterpenoids.
Table 1.  Chemical constituents from the Aristolochia (馬兜鈴 mǎ dōu ling) species.
Species Part Compound Reference
  A. species
aristolochic acid I; aristolochic acid A (1) Chen et al, 2010a
  A. albida
whole plant columbin (2) Nok et al, 2005
  A. arcuata
roots talaumidin (3) Zhai et al, 2004 Zhai et al, 2005
veraguensin (4) Zhai et al, 2005
galgravin (5)
aristolignin (6)
nectandrin A (7)
isonectandrin B (8)
nectandrin B (9)
  A. brevipes
ground roots β-sitosterol (10) Navarro-García et al, 2011
6α-7-dehydro-N-formyl-nornantenine (11)
E/Z-N-formylnornantenine (12)
7,9-dimethoxytariacuripyrone (13)
9-methoxytariacuripyrone (14)
aristololactam I (15)
stigmasterol (16)
3-hydroxy-α-terpineol (17)
  A. constricta
stems aristolochic acid A (1) Zhang et al, 2008
(18) Capasso et al, 2006
(19)
(20)
(21)
(22)
(23)
stems (−)-hinokinin (24) Zhang et al, 2008
9-O-[(−)-kaur-15-en-17-oxyl]cubebin (25)
(−)-cubebin (26)
(−)-kaur-15-en-17-ol (27)
(−)-pluviatolide (28)
(−)-haplomyrfolol (29)
(−)-dihydrocubebin (30)
9-O-methylcubebin (31)
(−)-kaur-16-en-19-oic acid (32)
(−)-kauran-16α,17-diol (33)
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Species Part Compound Reference
(−)-kaurene (34)
(−)-kauran-16α,17,18-triol (35)
aristololactam AII; aristolactam AII (36)
cepharanone B (37)
aristelegone A (38)
(+)-4,7-dimethyl-6-methoxy-1-tetralone (39)
cadalene (40)
β-sitosterol glucoside; β-sitosteryl glucoside (41)
N-trans-feruloyltyramine (42)
  A. contorta
fruits 3"-hydroxyamentoflavone-7-O-methyl ether (43) Chen et al, 2005
3"-hydroxyamentoflavone (44) 
  A. cretica
roots aristolochic acid I; aristolochic acid A (1) Georgopoulou et al, 2005
aristolochic acid IIIa; aristolochic acid C (45)
6-O-p-coumaroyl-β-D-fructofuranosyl-(2→1)-α-D- glucopyranoside (46)
arillatose B (47)
6-O-p-coumaroyl-α-D-glucopyranose (48)
6-O-p-coumaroyl-β-D-glucopyranose (49)
7-hydroxyaristolochic acid I (50)
aristolochic acid II; aristolochic acid B (51)
ariskanin A (52)
  A. cymbifera
whole plant 2-oxo-populifolic acid (53) de Barros Machado et al, 2005
leaves (−)-hinokinin (24) Sartorelli et al, 2010
(−)-kusunokinin (54)
(−)-copalic acid (55)
(−)-fargesin (56)
(+)-sesamin (57)
epieudesmin (58)
  A. elegans
stems and roots aristolochic acid I; aristolochic acid A (1) Shi et al, 2004
β-sitosterol (10)
(−)-hinokinin (24)
(−)-cubebin (26)
(−)-kaur-15-en-17-ol (27)
aristolactam AII; aristololactam AII (36)
aristelegone A (38)
β-sitosteryl glucoside (41)
N-trans-feruloyltyramine (42)
N-trans-cinnamyltyramine(54)
aristolactam E (59)
aristolactam-AIIIa-6-O-β-D-glucoside (60)
aristoquinoline A (61)
aristoquinoline B (62)
aristoquinoline C (63)
aristogin F (64)
9-methoxyaristolactam I (65)
isoaristolactam AII (66)
aristolactam AIIIa (67)
aristolactam C N-β-D-glucoside (68)
aristogin A (69)
aristogin B (70)
aristogin C (71)
aristogin D (72)
aristogin E (73)
4-methoxy-3,4'-oxydibenzoic acid (74)
aristelegone B (75)
aristelegone C (76)
aristelegone D (77)
pericampylinone A (78)
corydaldine (79)
thalifoline (80)

Kuo et al . / Journal of Traditional and Complementary Medicine 2 (2012) 
Species Part Compound Reference
northalifoline (81)
N-methylcorydaldine (82)
aristelegin A (83)
aristelegin B (84)
aristelegin C (85)
α-methylcubebin (86)
β-methylcubebin (87)
(−)-5"-methoxyhinokinin (88)
(−)-kobusin (89)
(+)-medioresinol (90)
aristolin (91)
ent-kauran-16β,17-diol (92)
ent-16β,17-epoxykauran (93)
ent-15β,16-epoxykauran-17-ol (94)
aristololide (95)
N-cis-feruloyltyramine (96)
N-p-trans-coumaroyltyramine (97)
aristolochic acid IVa; aristolochic acid D (98)
aristoloside (99)
aristolochic acid IV methyl ester (100)
methyl aristolochate; aristolochic acid I methyl ester (101)
aristolochic acid D methyl ester (102)
aristolochic acid Ia methyl ester (103)
magnofoline; magnoflorine (104)
oxonuciforine (105)
isomoschatoline (106)
4,5-dioxodehydroasimilobine (107)
methylparaben (108)
methyl vanillate (109)
p-hydroxybenzaldehyde (110)
vanillin (111)
methyl 4-hydroxy-3-methoxycinnamate (112)
cinnamic acid (113)
ω-hydroxypropioguaiacone (114)
ficusol (115)
  A. fangchi
roots aristolochic acid A; aristolochic acid I (1) Cai and Cai, 2010
aristolochic acid C; aristolochic acid IIIa (45)
aristolochic acid B; aristolochic acid II (51)
aristolochic acid F (116)
aristolochic acid G (117)
  A. gigantea
rhizomes β-sitosterol (10) Holzbach and Lopes, 2010
N-trans-feruloyltyramine (42)
magnoflorine (104)
allantoin (118)
E-nerolidol (119)
(+)-kobusin (120)
(+)-eudesmin (121)
aristolactam Ia N-β-D-glucoside (122)
aristolactam Ia 8-β-D-glucoside (123)
aristolactam IIIa (124)
aristolactam 9-O-β-D-glucopyranosyl-(1→2)-β-D-glucoside (125)
aerial stems N-trans-feruloyltyramine (42)
N-p-trans-coumaroyltyramine (97)
(+)-kobusin (120)
trans-N-feruloyl-3-O-methyldopamine (126)
N-cis-p-coumaroyl-3-O-methyldopamine (127) 
and N-trans-p-coumaroyl-3-O-methyldopamine (128)
  A. lagesiana
roots (−)-(8S,8’R ,9S)-cubebin (129) de Pascoli et al, 2006
(−)-(8R,8’R ,9R) and (−)-(8R,8’R ,9S)-cubebins (130)
(8R,8’R,8’’R,8’’’R ,9R ,9’’S)-bicubebin A (131)
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Species Part Compound Reference
  A. ligesiana
leaves (6R,6aS,P)-isocorydine (132) Ferreira et al, 2010
(6S,6aS,M)-isocorydine (133)
(6aS,M)-(+)-norisocorydine (134)
(6S,6aS,M)-(+)-corydine-N?oxide (135)
(6R,6aS,P)-(+)-corydine (136)
(6S,6aS,M)-corydine hydrochloride (137) and (6R,6aS,M)-corydine hydrochloride (138)
lagesianine A (139)
lagesianine B (140)
lagesianine C (141)
lagesianine D (142)
glycerol (143)
  A. malmeana
roots (−)-hinokinin (24) Messiano et al, 2008
(−)-kusunokinin (54)
(−)-(8S,8’R ,9S)-cubebin (129)
(−)-kolavenic acid (144)
leaves (−)-hinokinin (24)
(−)-kusunokinin (54)
(−)-copalic acid (55)
(−)-fargesin (56)
(−)-(8R,8’R ,9R) and (−)-(8R,8’R ,9S)-cubebins (130)
(−)-ent-6-β-hydroxycopalic acid (145)
(−)-phillygenin (146)
(−)-2-oxokolavenic acid (147)
  A. manshuriensis
stems aristolochic acid I; aristolochic acid A (1) Chung et al, 2011
aristolochic acid IIIa; aristolochic acid C (45)
aristolochic acid IVa; aristolochic acid D (98)
aristolochic acid-I methyl ester; methyl aristolochate (101)
aristolactam IIIa (124)
aristopyridinone A (148)
aristolamide (149)
aristolamide II (150)
aristolic acid methyl ester (151)
6-methoxyaristolic acid methyl ester (152)
  A. pubescens
roots and stems aristolochic acid A; aristolochic acid I (1) Nascimento et al, 2003
(−)-cubebin (26)
(−)-kaur-15-en-17-ol (27)
(+)-sesamin (57)
(+)-eudesmin (121)
tubercula (−)-(8S,8’R ,9S)-cubebin (129) de Pascoli et al, 2006
(−)-(8R,8’R ,9R) and (−)-(8R,8’R ,9S)-cubebins (130)
(8R,8’R,8’’R,8’’’R ,9R ,9’’S)-bicubebin A (131)
  A. ridicula
leaves ridiculuflavone A (153) Machado and Lopes, 2005
ridiculuflavone B (154)
ridiculuflavonylchalcone A (155)
proto-quercitol (156)   
ridiculuflavone C (157) Machado and Lopes, 2008
ridiculuflavone D (158)
ridiculuflavonylchalcone B (159)
ridiculuflavonylchalcone C (160)
  A. tagala
roots kaempferol (161) Battu et al, 2011
  A. taliscana
roots licarin A (162) León-Díaz et al, 2010
licarin B (163)
eupomatenoid-7 (164)
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Aristolochic acids and esters
The constituents from the Aristolochia  genus 
became the interesting topic for the phytochemical 
and pharmaceutical researchers since the discovery of 
aristolochic acid derivatives. The naturally occurring 
aristolochic acids possessed the 3,4-methylenedioxy- 
10-nitro-phenanthrenic-1-acid skeleton are typical 
constituents of the Aristolochia  species and claimed 
to be responsible for the various biological activity of 
Aristolochia species. Figure 1 lists the eight aristolochic 
acids that have been characterized from Aristolochia . 
Aristolochic acid I (1) is the most abundant aristolochic 
acid found in almost all species of Aristolochia studied 
with few exceptions. However, the main concern of 
recent studies has focused on the negative aspects of 
aristolochic acids due to the Chinese Herb Nephropathy 
(Cosyns, 2003). Recently health food supplements 
containing aristolochic acids have been prohibited for 
use in weight reduction with complete scientific results 
supported (The European Agency for the Evaluation 
of Medicinal Products, 1997; Therapuetic Goods 
Administration, 2001). In addition, seven methyl esters 
of aristolochic acid were reported from the Aristolochia 
species and among these only ariskanin A (52) did not 
possess the 3,4-methylenedioxy substitution pattern. 
Only few cases of aristolochic acid esters, including 
aristolic acid methyl ester (151) and 6-methoxyaristolic 
acid methyl ester (152), do not possess the nitro 
group at the C-10 position. The majority of these 
denitroaristolochic acids were reported from the 
Formosan A. manshuriensis  (Chung et al, 2011).
Aristolactams
Aristolactams are regarded as biogenetic intermediates 
in the biosynthetic pathway of aristolochic acids. 
They are usually supposed to originate from the 
cyclization condensation reaction of the reduction 
products of aristolochic acids. From Figure 2, it is 
evident that twelve aristolactams have been reported 
from Aristolochia species and among them there were 
also six compounds having the 3,4-methylenedioxy 
substitution groups. Aristolactam I (15), aristolactam 
AII (36), and aristolactam Ia N -β-D-glucoside (122) 
were the frequently encountered aristolactams in the 
Aristolochia  species. Aristolactam II (36) found in 
several species of Aristolochia is a simple aristolactam 
without any substitutions on rings B and C. The 
9-oxygenated aristolactams are rare in Aristolochia with 
only compounds 68 and 125 being reported. Compound 
125 was one example of 9-oxygenated aristolactam with 
the substitution of diglucoside.
Figure 1.  Aristolochic acids and esters from the Aristolochia species.
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Figure 2.  Aristolactams from the Aristolochia species.
N
O
R2O
R1O
R7
R3
R4
R5
R6
R1 R2 R3 R4 R5 R6 R7
15 CH2 H H OCH3 H H
36 CH3 H H H H H H
37 CH3 CH3 H H H H H
59 H CH3 H H OH OCH3 H
60 CH3 H H H H H OGlc
66 H CH3 H H H H H
67 CH3 H H H H H OH
68 CH2 Glc OCH3 OCH3 H OH
122 CH2 Glc H OH H H
123 CH2 H H Glc H H
124 CH2 H H H H OH
125 CH2 H OGlc-Glc OCH3 H H
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Aporphines
Seventeen aporphine alkaloids have been characterzied 
from Aristolochia  species (Figure 3). Aporphines 
with  N - formyl  subs t i tu t ion ,  6α,7-dehydro-N -
formylnornantenine (11) and N-formylnornantenine 
(12), were reported from A. brevipes (Navarro-García et 
al, 2011). The polar quaternary aporphine magnoflorine 
(104) was found in A. elegans  and A. gigantea . The 
4,5-dioxoaporphine is a small group of aporphine 
alkaloid found mostly among the Aristolochia ceae 
family and usually considered as possible intermediates 
of the precursors of aristolactams and aristolochic 
acids in plants. Only 4,5-dioxodehydro- asimilobine 
(107) was reported from A. elegans  (Shi et al, 2004). 
Most of the aporphines found in Aristolochia  species 
possess 4,5-tetrahydro basic skeleton. Lagesianines 
B-D (140-142) were the dimeric aporphine alkaloids 
linked through the substituent on nitrogen, oxygenated 
functions, and substituent on the phenanthrene ring, 
respectively. These dimeric aporphines were only 
reported from the leaves of A. ligesiana (Ferreira et al, 
2010).
Figure 3.  Aporphines from the Aristolochia species.
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Protoberberines
Occurrence of protoberberine alkaloids (Figure 
4) was rare in Aristolochia , and they were only 
reported from A. constricta  (Capasso et al, 2006). 
8-Benzyltetrahydroprotoberberine type alkaloid, 23, had 
been obtained by introduction of a benzyl group at C-8 
of berberine to result in this unusual carbon skeleton.
Isoquinolines 
The presence of isoquinoline alkaloids 78-82 
in the genus Aristolochia  is limited to A. elegans . 
Purified compounds of this class were listed in the 
Figure 5. All of these alkaloids reported possessed the 
tetrahydroisoquinolone basic skeleton. Isoquinoline 
alkaloids were usually considered as biogenetic 
intermediates in the catabolic process of bisbenzyl- 
tetrahydroisoquinoline alkaloids (Shi et al, 2004).
Figure 4.  Protoberberines from the Aristolochia species.
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H3CO
N
OH
H3CO
OH
23
R1 R2 R3
78 H H H
79 H H CH3
80 CH3 H CH3
81 H CH3 H
82 CH3 CH3 CH3
R2O
R3O
N
O
R1
O
CO2H
OR3
N
H3CO
H3CO R1
H R2
R1 R2 R3
61 CH3 O CH3
62 O CH3 CH3
63 O CH3 H
Figure 5.  Isoquinolines from the Aristolochia species.
Figure 6.  Benzylisoquinolines from the Aristolochia species.
Benzylisoquinolines
The occurrence of benzylisoquinoline type alkaloids, 
aristoquinolines A-C (61-63) constitute the first report 
of N-oxide benzoyl benzyltetrahydroisoquinoline ether 
alkaloids from Aristolochia  species (Figure 6). These 
provided the natural evidence for the catabolic process 
of structurally interesting bisbenzyltetrahydroisoquinol
ines. The isoquinolones, benzylisoquinolines, biphenyl 
ethers, and N -oxide benzoyl benzyltetrahydroisoqu
inoline ether alkaloids were derived biogenetically 
from bisbenzylisoquinolines, common metabolites 
of Aristolochia  species, in general alkaloid catabolic 
process (Shi et al, 2004).
Amides
The amides are another type of compounds isolated 
from several Aristolochia  plants (Figure 7). One class 
of the amides from Aristolochia  species, on structural 
investigation were found to contain a tyramine unit 
connected to phenolic acids like cis- or trans- coumaric 
and ferulic acids. Aristolamide (149) and aristolamide 
II (150) isolated from A. manshuriensis  (Chung et al, 
2011) contain –CONH2 group at C-1 which possessed 
the phenanthrene basic skeleton was another class of 
amide reported from Aristolochia species.
Flavonoids
Flavonoids continue to attract the researchers’ 
interests due to their structural diversity, biological and 
ecological significance. They affect plant interactions 
with microsymbionts (Romeo et al, 1998), insect 
predators and pollinators (Harborne, 1986; Stafford, 
1997), and also function in pigmentation and act as 
protectants against UV irradiation (Brouillard, 1988; 
Ylstra et al, 1992; Harborne, 1994). Virtually almost 
all higher plants produce flavonoids, however, some 
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Figure 7.  Amides from the Aristolochia species.
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Figure 8.  Flavonoids from the Aristolochia species.
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of them are fairly unique, in which many specific 
compounds are accumulated during plant growth and 
development. Six bisflavones, one unusual chalcone-
flavone dimer and two tetramers were characterzied 
from A. ridicula  (Machado and Lopes, 2005; 2008) 
(Figure 8). These reports constitute the presence of bi- 
and tetraflavonoids in the family Aristolochiaceae. In 
addition, there was also simple flavone reported from 
Aristolochia  species, like kaempferol (161) from A. 
tagala  (Battu et al, 2011).
Lignans
Lignans were another important type of metabolites 
found in several species of Aristolochia . There are 
five basic skeletons of neolignans and lignans with 
structural diversity reported from Aristolochia  genus 
(Figure 9), including diaryldimethyltetrahydrofuranoids, 
dibenzylbutanoids, benzofurans, and bisepoxylignans. 
The 2,5-diaryl-3,4-dimethyl- tetrahydrofuranoids 3-9 
were all characterized from the roots of A. arcuata (Zhai 
et al, 2004; 2005). Occurrence of the dibenzylbutane 
type lignans is the most common in Aristolochia 
genus. These lignans could be further divided into 
dibenzyltetrahydrofurans, dibenzylbutyrolactones, and 
dibenzylbutane diol depending on their oxidation states. 
Licarin A (162), licarin B (163), and eupomatenoid-7 
(164) were benzofuran type lignans only reported from 
A. taliscana (León-Díaz et al, 2010). The other type of 
lignans frequently encountered in Aristolochia species 
were the bisepoxylignans which were exemplified in 
Figure 9, reported from A. cymbifera , A. elegans, A. 
gigantea , and A. malmeana , respectively. In addition, 
there was also one dimeric lignan (8R, 8'R, 8''R, 8'''R , 
9R , 9''S)-bicubebin A (131) linked through the oxygen 
atom (de Pascoli et al, 2006).
Biphenyl ethers
Seven biphenyl ethers had been reported, including 
aristogins A-E (69-73), F (64), and 4-methoxy-
3,4-oxydibenzoic acid (74) (Figure 10). All these 
compounds have only been reported from A. elegans 
(Shi et al, 2004) and they are usually considered as 
one of the end products in the catabolic process of 
bisbenzylisoquinoline alkaloids.
Coumarins
Although there were only two coumarins, 7,9-dimeth
oxytariacuripyrone (13) and 9-methoxytariacuripyrone 
(14), characterized from the roots of A. brevipes  
(Figure 11), these constituents also displayed significant 
physiological activity (Navarro-García et al, 2011).
Tetralones
Among five tetralones reported from Aristolochia 
species so far (Figure 12), four tetralones, aristelegones 
A-D (38, 75-77) have been characterized in the stems 
and roots of A. elegans  collected in Taiwan (Shi et 
al, 2004). Aristelegone A (38) and (+)-4,7-dimethyl-
6-methoxy-1- tetralone (39) were reported from the 
stems of A. constricta  (Zhang et al, 2008). Most of 
these identified tetralones possessed a keto substituent 
at C-1 except that aristelegone D (77) had 1,2-diol 
functionalities.
OR1
R2
O
R3
R1 R2 R3
64 CH3 CO2H CH2OH
69 CH3 CHO CO2CH3
70 CH3 CO2CH3 CHO
71 CH3 CO2CH3 CO2CH3
72 H CO2CH3 CO2CH3
73 CH3 CO2CH3 CH2OH
CO2H
O
CO2H
74
H3CO
Figure 10.  Biphenyl ethers from the 
Aristolochia species.
Figure 11.  Coumarins from the Aristolochia species. 
O
OCH3
R2
R1
O
13 R1 = OCH3, R2 = OCH3
14 R1 = NO2, R2 = H
Figure 12.  Tetralones from the Aristolochia species.
R3
R4
O
R1
R2
R1 R2 R3 R4
38 H CH3 OH CH3
39 H CH3 OCH3 CH3
75 OH CH3 OCH3 CH3
76 H CH3 OH CH2OH
77
H3CO
H3C
CH3
OH
OH
2
Kuo et al . / Journal of Traditional and Complementary Medicine 2 (2012) 
OH
OH
17 40
O H
H H
OCOCH3
H
H
95
OH
119
O
53
O
OH
H
OH
O
144
O
H
OH
O
147
O
OH
H
H
CH3
CH3
H
O
O
O O
2
OH
O
55
OH
O
OH
145 27
H
H
H
OH
32
COOH
H
H
H
33
H
H
H
OH
OH
34
H
H
H
35
H
H
H
OH
OH
OH
H
H
OH
92
OH
H
H
H
O
93
H
H
H O
94
H
OH
H
H
O
O
O
O
O
O
25
H
H
CH2OH
O
O
C
NO2
O
OCH3
O
91
Figure 13.  Terpenoids from the Aristolochia species.
261
Kuo et al . / Journal of Traditional and Complementary Medicine 2 (2012) 
Terpenoids
Although there were so many terpenoids characterized 
from Aristolochia  species in our previous review (Wu 
et al, 2005), the number of terpenoids reported in the 
period between 2004 and 2011 was comparatively 
limited (Figure 13). Only one monoterpene, 3-hydroxy-
α-terpineol (17), was identified from the roots of 
A. brevipes  (Navarro-García et al, 2011). Three 
sesquiterpenoids, cadalene (40) (Zhang et al, 2008), 
aristololide (95) (Shi et al, 2004), and E-nerolidol (119) 
(Holzbach and Lopes, 2010), belonged to the cadinane, 
bourbonanes, and farnesane basic skeleton, respectively, 
were also characterized from the Aristolochia species. 
The diterpenoids with three types of C20 carbon 
skeletons constitute the largest group of terpenoid 
metabolites in Aristolochia . First type of diterpenoid 
is the clerodane basic skeleton. 2-Oxo-populifolic 
acid (53) was reported from A. cymbifera  and 
(−)-kolavenic acid (144) and (−)-2-oxokolavenic acid 
(147) were purified from A. malmeana , respectively. 
A furanolactone diterpene belonged to the clerodane 
type was isolated from the rhizomes of A. albida (Nok 
et al, 2005) and identified as columbin (2). Second type 
is labdanes in which only (−)-copalic acid (55) and 
(−)-ent-6-β-hydroxycopalic acid (145) possessed this 
basic skeleton that were only a little different from the 
clerodane type diterpenoids. From the reports up to date, 
it revealed that Aristolochia species were rich sources 
of ent -kaurane diterpenoids. In our reviewing period, 
totally eight ent-kaurane diterpenoids were reported 
from A. constricta , A. elegans , and A. pubescens . 
In addition, one ent -kaurane lignan 9-O -[(−)-kaur-
15-en-17-oxyl]cubebin (25), and one ent -kaurane 
diterpenoid ester of aristolochic acid aristolin (91) were 
also characterized from A. constricta  and A. elegans , 
respectively. Aristolin (91) is the first example of an 
ester composed of aristolochic acid and a diterpenoid, in 
which C-16 hydroxy group of ent-kauran-16-β, 17-diol 
involves in the ester linkage with C-11 carboxylic acid 
group of aristolochic acid (Shi et al, 2004).
Benzenoids
A number of benzenoid derivatives were isolated 
from different Aristolochia  species, which include 
phenylmethanoids and phenylpropanoids (Figure 
14). Four simple benzenoid derivatives 108-111 were 
isolated from the stems and roots of A. elegans (Shi et 
al, 2004). Eight phenylpropanoids, including aglycones 
112-115 from A. elegans  and glycosides 46-49 from A. 
cretica , respectively, were reported and most of them 
are ferulic, cinnamic, p-coumaric, and caffeic acids 
derivatives.
Steroids and others
Steroids are usually encountered in natural sources, 
and those presented in Aristolochia species are mostly 
derivatives of β-sitosterol and stigmasterol. Among 
these steroids, β-sitosterol (10) and β-sitosteryl 
glucoside (41) were frequently found in several 
Aristolochia  species (Figure 15). In addition, some 
miscellaneous compounds including glycerol (143) 
and proto-quercitol (156) were also reported from 
Aristolochia species.
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Pharmacology
There were a lot of worthy achievements related to 
the pharmacology of Aristolochia  to be published to 
evidence the extensive use of Aristolochia  species in 
folk/traditional medicines. The aristolochic acids have 
been considered to be the most potent fraction of the 
Aristolochia  constituents. Aristolochic acid I, the most 
active constituent of Aristolochia  has been used for 
medicinal purposes since the Graeco-Roman period. 
However, following the observations that the compound 
was mutagenic and carcinogenic, it was removed from 
pharmaceutical products since a decade (Pharmacopoeia 
of the People’s Republic of China, 1977). Various 
bioactivity studies have been reported to assess the 
traditional uses of Aristolochia species and these results 
were summarized in Table 2. Some of the Aristolochia 
species, including A. baetica , A. bracteolata , A. 
indica , A. malmeana , and A. pubescens , have been 
reported to exhibit insecticidal and repellent activities. 
The crude extracts of A. brevipes , A. cymbifrea , A. 
indica , A. mollissima , and A. taliscana  also display 
significant antimicrobial activities. The phytochemical 
compositions and pharmacology of Aristolochia genus 
have evoked a great deal of interest due to their multiple 
traditional uses and various bioactivity reports on their 
crude extracts. Therefore, Aristolochia  become one of 
the intensely investigated genera and a large number 
of papers have been published on the production of 
physiologically important metabolites by Aristolochia. 
The divergent bioactivities reports of the compounds 
identified from the Aristolochia  species was listed in 
Table 3. It was famous that in the previous studies 
aristolochic acid I (1) exhibited significant cytotoxicity 
thus aristolochic acid I (1) (Chen et al, 2010a), 
aristolochic acid-IVa (98), aristolactam IIIa (124), and 
aristolamide II (150) (Chung et al, 2011) were examined 
for their anti-inflammatory potentials and displayed 
significant effects. The lignans purified from A. 
arcuata , talaumidin (3), galgravin (5), aristolignin (6), 
nectandrin A (7), isonectandrin B (8), and nectandrin 
B (9) all exhibited neuroprotective bioactivity (Zhai et 
al, 2005). In addition, (−)-hinokinin (24), (−)-cubebin 
(26), (−)-pluviatolide (28), and (−)-haplomyrfolol (29) 
from A. constricta also displayed antispasmodic activity. 
There was also one diterpenoid, (−)-kaur-16-en-19-
oic acid (32) to show the antispasmodic effect (Zhang 
et al, 2008). A. constricta is a medicinal plant found in 
Ecuador and widely distributed in South America. The 
protoberberines 18-21 from A. constricta  exhibited the 
Table 2.  Bioactivity of the crude extracts of the Aristolochia (馬兜鈴 
mǎ dōu ling) species.
Source Parts Bioactivity Reference
A. baetica stem insecticidal Jbilou et al, 2008
roots antiproliferative Chaouki et al, 
2010
A. bracteolata whole 
plant
antiplasmodial
antiallergic
Ahmed et al, 
2010
Chitme et al, 
2010
leaves antifeedant Elango et al, 
2011
A. brevipes ground 
roots
antimycobacterial Navarro-García 
et al, 2011
A. constricta stems antispasmodic Zhang et al, 
2008
A. cymbifrea whole 
plant
antimicrobial de Barros 
Machado et al, 
2005
stems antibacterial Alviano et al, 
2008
A. elegans roots and 
aerial 
part
anti scorpion 
venom
Izquierdo et al, 
2010
roots anti scorpion 
venom
Jiménez-Ferrer 
et al, 2005
A. indica roots antibacterial Kumar et al, 
2006
antifungal Kumar et al, 
2006
leaves anti snake venom Samy et al, 2008
leaves mosquito-
adulticidal
Kamaraj et al, 
2010
mosquito-
repellent
Kamaraj et al, 
2010
mosquito-
larvicidal
Kamaraj et al, 
2010
A. malmeana roots insecticidal Messiano et al, 
2008
A. mollissima rhizome 
and aerial 
part
antimicrobial Yu et al, 2007
A. pubescens roots and 
stems
insecticidal Nascimento et 
al, 2003
A. tagala 
(syn: A. 
acuminata)
roots antiinflammatory Battu et al, 2011
A. taliscana roots antimycobacterial León-Díaz et al, 
2010
anti-addictive effects and these results indicated that 
the alkaloids were able to produce significant influence 
on the opiate withdrawal in vitro and these compounds 
were able to exert their effects both at μ and κ opioid 
agonists (Capasso et al, 2006). 
Licarin A (162), licarin B (163), and eupomatenoid-7 
(164) reported from A. taliscana  (León-Díaz et 
al, 2010); and 7,9-dimethoxytariacuripyrone (13), 
9-methoxytariacuripyrone (14), and aristololactam I 
(15) from A. brevipes (Navarro-García et al, 2011) were 
examined for their antimycobacterial effects and the 
results confirmed their potentials indicated in the crude 
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extracts. Mycobacterium tuberculosis  (MTB) is one of 
the species of the so-called tuberculosis complex and is 
the causative agent of tuberculosis (TB). The increase 
in the number of cases of TB has been associated with 
the infection of humans with HIV, in addition to the 
appearance and development of TB-resistant drugs, both 
multidrug-resistant (MDR), as well as extremely drug-
resistant (XDR). These studies demonstrated that the 
dichloromethane extracts of rhizomes of A. brevipes  
and hexane extracts of A. taliscana possesses strong in 
vitro antimycobacterial activity against Mycobacterium 
tuberculosis  strains. Among the tested compounds, 
licarin A (162) was the most active compound, with 
minimum inhibitory concentrations (MICs) of 3.12-12.5 
μg/mL against the following M. tuberculosis  strains: 
H37Rv, four mono-resistant H37Rv variants and 12 
clinical MDR isolates, as well as against five non-
tuberculous mycobacteria (NTM) strains. 
Table 3.  Bioactivity of the compounds identified from the Aristolochia (馬兜鈴 smǎ dōu ling) species.
Compound Source Bioactivity Reference
aristolochic acid I (1) antiinflammatory Chen et al, 2010a
A. constricta antispasmodic Zhang et al, 2008
A. pubescens insecticidal Nascimento et al, 2003
A. fangchi antiplatelet Shen et al, 2008
aristolochic acid A (1) A. fangchi cytotoxic Cai and Cai, 2010
columbin (2) A. albida trypanocidal Nok et al, 2005
antitrypanosomal
talaumidin (3) A. arcuata neurotrophic Zhai et al, 2004
Zhai et al, 2005
neuroprotective Zhai et al, 2005
galgravin (5) A. arcuata neurotrophic Zhai et al, 2005
aristolignin (6) A. arcuata neurotrophic Zhai et al, 2005
nectandrin A (7) A. arcuata neurotrophic Zhai et al, 2005
neuroprotective
isonectandrin B (8) A. arcuata neurotrophic Zhai et al, 2005
neuroprotective
nectandrin B (9) A. arcuata neurotrophic Zhai et al, 2005
neuroprotective
7,9-dimethoxytariacuripyrone (13) A. brevipes antimycobacterial Navarro-García et al, 2011
9-methoyitariacuripyrone (14) A. brevipes antimycobacterial Navarro-García et al, 2011
aristololactam I (15) A. brevipes antimycobacterial Navarro-García et al, 2011
(18) A. constricta anti-addictive Capasso et al, 2006
(19) A. constricta anti-addictive Capasso et al, 2006
(20) A. constricta anti-addictive Capasso et al, 2006
(21) A. constricta anti-addictive Capasso et al, 2006
(−)-hinokinin (24) A. constricta antispasmodic Zhang et al, 2008
A. cymbifera antitrypanosomal Sartorelli et al, 2010
(−)-cubebin (26) A. constricta antispasmodic Zhang et al, 2008
(−)-kaur-15-en-17-ol (27) A. pubescens insecticidal Nascimento et al, 2003
(−)-pluviatolide (28) A. constricta antispasmodic Zhang et al, 2008
(−)-haplomyrfolol (29) A. constricta antispasmodic Zhang et al, 2008
(−)-kaur-16-en-19-oic acid (32) A. constricta antispasmodic Zhang et al, 2008
(−)-kusunokinin (39) A. malmeana insecticidal Messiano et al, 2008
aristolochic acid II (51) A. fangchi antiplatelet Shen et al, 2008
2-oxo-populifolic acid (53) A. cymbifera antimicrobial de Barros Machado et al, 2005
(−)-kusunokinin (54) A. cymbifera antitrypanosomal Sartorelli et al, 2010
(−)-copalic acid (55) A. cymbifera antitrypanosomal Sartorelli et al, 2010
(−)-fargesin (56) A. cymbifera antitrypanosomal Sartorelli et al, 2010
(+)-sesamin (57) A. cymbifera antitrypanosomal Sartorelli et al, 2010
epieudesmin (58) A. cymbifera antitrypanosomal Sartorelli et al, 2010
(+)-eudesmin (82) A. pubescens insecticidal Nascimento et al, 2003
aristolochic acid IVa (98) A. manshuriensis antiinflammatory Chung et al, 2011
(+)-sesamin (121) A. pubescens insecticidal Nascimento et al, 2003
aristolactam IIIa (124) A. manshuriensis antiinflammatory Chung et al, 2011
cyclin-dependent kinase inhibiting Hegde et al, 2010
aristolamide II (150) A. manshuriensis antiinflammatory Chung et al, 2011
kaempferol (161) A. tagala antiinflammatory Battu et al, 2011
licarin A (162) A. taliscana antimycobacterial León-Díaz et al, 2010
licarin B (163) A. taliscana antimycobacterial León-Díaz et al, 2010
eupomatenoid-7 (164) A. taliscana antimycobacterial León-Díaz et al, 2010
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Chagas disease is a chronic illness caused by the 
flagellate protozoan Trypanosoma cruzi , and it is 
the major cause of morbidity and mortality in many 
regions of South America. A. cymbifera  has been 
used in traditional medicine as an abortifacient and 
an emmenagogue as well as in the treatment of fever, 
diarrhea, and eczema. The experimental results of 
purification of A. cymbifera  and bioactivity study 
demonstrated that (−)-kusunokinin (54) and (−)-copalic 
acid (55) were the most active compounds against 
trypomastigotes of T. cruzi . Additionally, (−)-copalic 
acid (55) demonstrated the highest parasite selectivity 
as a result of low toxicity to mammalian cells, despite a 
considerable hemolytic activity at higher concentrations. 
Among the isolated compounds, (−)-kusunokinin (54) 
could be considered the most promising candidate, as 
it displayed significant activity against intracellular 
amastigotes and trypomastigotes without hemolytic 
activity (Sartorelli et al, 2010).
Nephrotoxicity
Chinese herbs nephropathy (CHN) is a rapidly 
progressive interstitial nephropathy reported after the 
introduction of Chinese herbs in a slimming regimen 
followed by young Belgian women (Vanherweghem et 
al, 1993; Nortier et al, 2000). Because of manufacturing 
error, there were several reports on the adverse effects 
of this slimming regimen. Firstly, in 1992, some cases 
of women presenting with a rapidly progressive renal 
failure after having followed a slimming regimen 
including powdered extracts of Chinese herbs, one of 
them being Stephania tetrandra  were recorded. This 
outbreak of renal failure eventually resulted in about 
100 cases in 1998, 70 % of them being in end-stage 
renal disease (ESRD) (Vanherweghem, 2002). Chinese 
herbs nephropathy is characterized by early, severe 
anemia, mild tubular proteinuria and initially normal 
arterial blood pressure in half of the patients (Cosyns, 
2003). The recent studies have confirmed that the main 
culprit leading to renal injury is aristolochic acid found 
in many Chinese herbal preparations (Balachandran et 
al, 2005; Nedelko et al, 2009; Chen et al, 2010b; Zhu et 
al, 2010; Chen et al, 2012). Aristolochic acid, a potent 
human carcinogen produced by Aristolochia  plants, 
is associated with urothelial carcinoma of the upper 
urinary tract (UUC). Following metabolic activation, 
aristolochic acid reacts with DNA to form aristolactam 
(AL)-DNA adducts. These lesions concentrate in 
the renal cortex, where they serve as a sensitive and 
specific biomarker of exposure, and are found also 
in the urothelium, where they give rise to a unique 
mutational signature in the TP53 tumor-suppressor gene. 
From the research results, it could be concluded that 
exposure to aristolochic acid contributed significantly 
to the incidence of UUC, a finding with significant 
implications for global public health (Chen et al, 2012).
Conclusion
This review of literature including phytochemical and 
pharmacological investigations on Aristolochia species 
have covered 164 compounds belonged to the classes of 
aristolochic acids and esters, aristolactams, aporphines, 
protoberberines, isoquinolines, benzylisoquinolines, 
amides, flavonoids, lignans, biphenyl ethers, coumarins, 
tetralones, terpenoids, benzenoids, steroids, and others 
with extensive physiological activities. Recently, 
the focus of the pharmacology of the Aristolochia 
species was mainly on the nephrotoxic aristolochic 
acids responsible for a tragic disease of Chinese herb 
nephropathy recognized in 1992. It may thus be of 
more than academic interest to examine the remaining 
Aristolochia plants for their aristolochic acid presence 
to prevent the issues like Chinese herb nephropathy 
and Balkan endemic nephropathy. This review will 
help researchers and scientists in locating the detailed 
information on Aristolochia  species and address the 
continuous development in the phytochemistry and the 
therapeutic application of the Aristolochia species in the 
period between 2004 and 2011.
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